Search

everythinglearnresearchcommunity

for

Search:↓

Hormonal treatments can change hair and skin in transgender people, but may not fully achieve desired results.

Testosterone therapy in transgender men has both desired effects like increased muscle mass and potential health risks such as higher cardiovascular risk.

Dermatologists should address discrimination and consider ethnic and gender differences in treatments.

The discovery of 5α-reductase deficiency in guevedoces led to the development of important urologic medications.

Understanding gender differences in COVID-19 is crucial for effective health strategies.

A new genetic change causing early stop in the androgen receptor gene was found in a patient with androgen insensitivity syndrome.

Dihydrotestosterone makes arteries stiffer in female mice by reducing estrogen receptor expression.

Accurate diagnosis and early specialist referral are crucial for managing 46,XY Disorders of Sex Development.

Hormone treatment for transsexual individuals is effective but carries risks like thromboembolic events and mood changes, with most side effects being minor and reversible.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Dermatologists should guide transgender patients on effective hair growth and loss treatments during hormone therapy.

Large language models often give biased or inaccurate medical responses, especially for LGBTQIA+ prompts.

Benign conditions can mimic serious ones in postmenopausal hyperandrogenism, requiring careful diagnosis.

Future hormone therapy trials should match the diverse needs and priorities of the gender-diverse community.

Goserelin injections can effectively manage hyperandrogenism symptoms in postmenopausal women who can't have surgery.

Male mice with FGF5 mutations grow longer hair than females.

Transgender acne treatment requires a tailored approach with ongoing topical treatments and ceramide-rich moisturizers.

Mutations in the androgen receptor gene cause Androgen Insensitivity Syndrome, affecting sexual development.

Androgen receptors are active in many tissues of both male and female mice, not just reproductive organs.

GnRH-a or orchiectomy is more effective than anti-androgens for managing hormone levels in transgender women.

The document concludes that there is a significant lack of reporting on the sex and age of cells in skin research, which could affect clinical trials and treatments.

Gender-diverse individuals face more depression and anxiety, possibly due to unique stress profiles.

Testosterone therapy in transgender men can lead to hair loss, with the risk increasing over time and influenced by family history.

Impaired androgen production in 46,XY DSDs causes ambiguous genitalia and requires long-term care.

The document concludes that Hilary Mantel's memoir shows how childhood experiences affect adult health, criticizing modern medicine for ignoring the mental aspects of physical illness.

Five new mutations in the androgen receptor gene were found, helping to understand androgen insensitivity syndrome better.

Women and men experience different quality of life and symptom distress after kidney transplant with immunosuppressive therapy.

Inclusive and culturally competent healthcare is crucial for transgender and non-binary individuals.

Following national healthy eating guidelines can help reduce risks from gender-affirming hormone therapy.

Too much male hormone in mothers can negatively affect the sexual behavior of both male and female baby mice.